Mar. Drugs 2010, 8(7), 2117-2128; doi:10.3390/md8072117

Neuroprotective Properties of Chitosan and Its Derivatives

1email and 1,2,* email
Received: 25 June 2010; in revised form: 5 July 2010 / Accepted: 9 July 2010 / Published: 9 July 2010
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Neuronal cells are extremely vulnerable and have a limited capacity for self-repair in response to injury. For those reasons, there is obvious interest in limiting neuronal damage. Mechanisms and strategies used in order to protect against neuronal injury, apoptosis, dysfunction, and degeneration in the central nervous system are recognized as neuroprotection. Neuroprotection could be achieved through several classes of natural and synthetic neuroprotective agents. However, considering the side effects of synthetic neuroprotective agents, the search for natural neuroprotective agents has received great attention. Recently, an increasing number of studies have identified neuroprotective properties of chitosan and its derivatives; however, there are some significant challenges that must be overcome for the success of this approach. Hence, the objective of this review is to discuss neuroprotective properties of chitosan and its derivatives.
Keywords: neuronal cells; neuroprotection; neuroprotective agents; neuroprotective properties; chitosan and derivatives
PDF Full-text Download PDF Full-Text [176 KB, uploaded 9 July 2010 16:51 CEST]

Export to BibTeX |

MDPI and ACS Style

Pangestuti, R.; Kim, S.-K. Neuroprotective Properties of Chitosan and Its Derivatives. Mar. Drugs 2010, 8, 2117-2128.

AMA Style

Pangestuti R, Kim S-K. Neuroprotective Properties of Chitosan and Its Derivatives. Marine Drugs. 2010; 8(7):2117-2128.

Chicago/Turabian Style

Pangestuti, Ratih; Kim, Se-Kwon. 2010. "Neuroprotective Properties of Chitosan and Its Derivatives." Mar. Drugs 8, no. 7: 2117-2128.

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert